Grade My Investments
Home › Free Stock Grades › ANGO

AngioDynamics, Inc. (ANGO) Stock Grade

ANGO · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$642.3M
P/E Ratio
—
Revenue Growth (YoY)
+9.5%
Net Margin
-11.5%
Return on Equity
—
Dividend Yield
None

About AngioDynamics, Inc.'s fundamentals

AngioDynamics is a medical device company with a market capitalization of $642.3 million that generated 9.5% year-over-year revenue growth in its latest period. However, the company operates at a net loss with a negative net margin of -11.5%, reflecting below-breakeven profitability on its current revenue base. Despite accounting losses, the company maintains positive free cash flow, suggesting its operational cash generation exceeds its accounting expenses. The company does not pay a dividend.

Track ANGO free — no credit card required. Live grade + monthly AI report →